Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Elevated thymidine phosphorylase has been shown to correlate with increased angiogenesis and poor prognosis in many cancers including transitional cell carcinoma of the bladder. In vitro studies have demonstrated that thymidine phosphorylase activity causes cellular oxidative stress and increases secretion of vascular endothelial growth factor. In this study, we show that thymidine phosphorylase activity also augments levels of the hypoxia-inducible factor-1alpha during in vitro hypoxia, and that thymidine phosphorylase activity and hypoxia act in concert to increase vascular endothelial growth factor (VEGF) secretion. We also demonstrate that thymidine phosphorylase overexpression confers tumorigenicity on an orthotopically implanted transitional cell carcinoma cell line. Administration of the antioxidant N-acetylcysteine together with a blocking anti-VEGF antibody abrogates the increase in tumorigenicity. Our results support the increased efficacy of combination approaches to antiangiogenic therapy.

Original publication

DOI

10.1038/sj.bjc.6602522

Type

Journal article

Journal

Br J Cancer

Publication Date

09/05/2005

Volume

92

Pages

1696 - 1701

Keywords

Animals, Antibodies, Monoclonal, Carcinoma, Transitional Cell, Cell Hypoxia, Neoplasm Transplantation, Oxidative Stress, Rats, Rats, Nude, Reactive Oxygen Species, Thymidine, Thymidine Phosphorylase, Transfection, Tumor Cells, Cultured, Urinary Bladder Neoplasms, Vascular Endothelial Growth Factors